J&J makes a $100 million diversity pledge. Does it go far enough?
The pledge arrived as the pandemic continued its surge, with minority communities particularly hard hit, and as cultural dialogue heated up within the industry.
Most recent articles by Marc Iskowitz
GCI Health names Kristin Cahill its next global CEO
Cahill assumes the role on January 1, as current chief exec Wendy Lund departs for a comms role at Merck spinoff Organon.
At 94.5% efficacy, Moderna’s COVID-19 vaccine appears comparable to Pfizer/BioNTech’s candidate
Both vaccines have been shown to have 90%-95% efficacy. Differences in how they need to be stored could dictate how the shots are distributed.
Messaging the COVID-19 vaccine: No shot is an antidote to community concerns
Getting more people interested in vaccination will depend on a pivot from a biomedical mode of discussing vaccination to a more civic conversation, urges one public health expert in this Q&A.
Pfizer/BioNTech’s COVID-19 vaccine: An ‘A’ for efficacy and, potentially, for restoring hope
The vaccine candidate showed a 90% efficacy rate in preventing infections. The data came the same day President-Elect Biden advanced his plan to control the pandemic.
‘It’s real life.’ Pharma’s content creators adapt to coronavirus, embrace reality
From COVID-safe photography to letting patients direct and produce their own videos, pharma’s commercial tactics – and their results – look a lot different nowadays.
The ‘COVID-proof’ drug launch? Why telemedicine could become a staple for more pharma brands
Telemedicine integration — connecting patients “from ad to doctor” — is poised to become a fixture of multichannel drug marketing.
Stalled HHS coronavirus ad campaign sought to capitalize on star power, but public-health push came too late
The Department of Health and Human Services drafted public health officials and celebs to push a “defeat despair” message. But if this qualifies as an embrace of science, it’s too late.
NPs, PAs are calling on marketers to adjust educational, promotional pitches
Amid the pandemic, nurse practitioners and physician assistants have seen their practice authority surge. They’d like marketers to adjust their educational and promotional pitches accordingly.
How Teladoc’s takeover of Livongo may hasten the era of virtual care
Fresh off the firm’s $18.5 billion megadeal to acquire Livongo, Teladoc’s chief medical officer says it’s working to find the right mix of virtual and in-person care.
